The immunomodulatory effects of estrogens: Clinical relevance in immune-mediated rheumatic diseases: Annals of the New York Academy of Sciences

Annals of the New York Academy of Sciences

Volumn 1193, Issue , 2010, Pages 36-42

  Cutolo, Maurizio ^a   Brizzolara, Renata ^a   Atzeni, Fabiola ^b   Capellino, Silvia ^c   Straub, Rainer H ^c   Puttini, Pier Carlo Sarzi ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Aromatase; Autoimmune rheumatic diseases; Estrogens; Rheumatoid arthritis; Sex hormones; Systemic lupus erythematosus

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE SULFATE; ORAL CONTRACEPTIVE AGENT; PRINABEREL; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG TARGETING; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; NONHUMAN; ORAL CONTRACEPTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; TARGET CELL;

ANIMALIA;

EID: 77951228956     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05383.x     Document Type: Conference Paper

References (31)

1. Cutolo, M., S. Capellino & R.H. Straub. 2008. Estrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford). 47(Suppl 3): iii2-iii5.
2. Cutolo, M. & R.L. Wilder. 2000. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum. Dis. Clin. N. Am. 26: 825-839.
3. Taneja, V., M. Behrens, A. Mangalam, et al. 2007. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum. 56: 69-78.
4. Cutolo, M. 2007. Sex and rheumatoid arthritis: mouse model versus human disease. Arthritis Rheum. 56: 1-3.
5. Holmdahl, R. 2007. The use of animal models for rheumatoid arthritis. Methods Mol. Med. 136: 185-189.
6. Rigby, R.J., M.M. Fernando & T.J. Vyse. 2006. Mice, humans and haplotypes-the hunt for disease genes in SLE. Rheumatology 4: 1062-1067.
7. Hall, J.M.&D.P.McDonnell. 1999. The estrogen receptor b-isoform (ERb) of the human estrogen receptor modulates ERa transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140: 5566-5578.
8. Schneider,C.P., E.A.Nickel,T.Samy, et al. 2000. The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock 14: 347-353.
9. Tamir, S., S. Izrael & J. Vaya. 2002. The effect of oxidative stress on ERa and ERb expression. J. Steroid Biochem. Mol. Biol. 81: 327-332.
10. Cvoro, A., D. Tatomer & M.K. Tee. 2008. Selective estrogen receptor- agonists repress transcription of proinflammatory genes. J. Immunol. 180: 630-636.
11. Ishizuka,M., M.Hatori, T. Suzuki, et al. 2004. Sex steroid receptors inrheumatoid arthritis. Clin. Sci. 106: 293-300.
12. Rogers, A. & R. Eastell. 2001. The effect of 17b-estradiol on production of cytokines in cultures of peripheral blood. Bone 29: 30-34.
13. Schmidt, M., C. Weidler, H. Naumann, et al. 2005. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes-androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5 alpha-reduced androgens. Arthritis Res. Ther. 7: R938-R948.
14. Brodsky, A., M. Cutolo, A. DerMovsesian, et al. 2007. The efficacy and safety of 3 oral doses of ERB-041 in subjects with rheumatoid arthritis on a background of methotrexate therapy. Arthritis Rheum. 57: S270.
15. Asai, K., N. Hiki, Y. Mimura, et al. 2001. Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPSinduced cytokine secretion in an ex vivo septic model. Shock 6: 340-343.
16. Ralston, S.H., R.G. Russell & M. Gowen. 1990. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone. Miner. Res. 5: 983-988.
17. Cutolo, M., P. Montagna, S. Capellino, et al. 2005. Sex hormone modulation of cell growth and apoptosis of human monocytic/macrophage cells. Arthritis Res. Ther. 7: R1124-R1132.
18. Capellino, S., B. Riepl, L. Rauch, et al. 2007. Quantitative determination of steroid hormone receptor positive cells in synovium of RA and OA patients: is there a link to inflammation? Ann. Rheum. Dis. 66: 53-58.
19. Cutolo, M., B. Villaggio, B. Seriolo, et al. 2004. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun. Rev. 3: 193-198.
20. Tengstrand, B., K. Carlstron, L. Fellander-Tsai, et al. 2003. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J. Rheumatol. 30: 2338-2343.
21. Folomeev, M., M. Dougados, J. Beaume, et al. 1992. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1: 191-195.
22. Weidler,C., P.Harle, X. Schedel, et al. 2004. Patientswith rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J. Rheumatol. 31: 489-494.
23. Schmidt, M., R. Hartung, S. Capellino, et al. 2009. Estrone/17beta- estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum. 60: 2913-2922.
24. Capellino, S., P. Montagna, B. Villaggio, et al. 2008. Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. Clin. Exp. Rheumatol. 26: 903-909.
25. Bernier,M.O.,Y.Mikaeloff, M.Hudson&S. Suissa. 2009. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum. 61: 476-481.
26. Hudson, M., B. Thombs & M. Baron. 2009. Time to diagnosis in systemic sclerosis: is sex a factor? Canadian Scleroderma Research Group. Arthritis Rheum. 61: 274-278.
27. Schneider, J., M.M. Huh, H.L. Bradlow & J. Fishman. 1984. Antiestrogen action of 2-hydroxyestrone on MCF- 7 human breast cancer cells. J. Biol. Chem. 259: 4840-4845.
28. Swaneck, G.E. & J. Fishman. 1988. Covalent binding of the endogenous estrogen 16a-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA 85: 7831-7835.
29. Cutolo, M. 2009. Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res. Ther. 11: 126-129.
30. Straub, R.H. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28: 521-574.
31. Cutolo,M.&R.H. Straub. 2009. Insights into endocrineimmunological disturbances in autoimmunity and their impact on treatment. Arthritis Res. Ther. 11: 218-222.